文献速递胃肠外科围术期管理与 ERAS

代谢手术减重与COVID-19感染风险及严重程度的关联

Association of Weight Loss Achieved Through Metabolic Surgery With Risk and Severity of COVID-19 Infection.
PubMed 文献 · JAMA Surg · 2022-01-01

这项队列研究纳入体重指数≥35的成人,比较减重手术组与对照组。手术组10年减重更多且全因非COVID-19死亡率更低。手术组SARS-CoV-2阳性率与对照组相当,但住院、需补氧和重症COVID-19风险更低。

要点

  • 减重手术与较低的COVID-19住院、补氧和重症风险相关
  • 手术组与对照组SARS-CoV-2阳性率无显著差异
  • 肥胖可能是COVID-19严重程度可干预的危险因素

核心结论

  • 在肥胖患者中,通过手术实现大幅减重与COVID-19感染结局改善相关,提示肥胖可能是COVID-19严重程度可干预的危险因素。

研究设计与样本

  • 这项队列研究纳入2004年1月1日至2017年12月31日在Cleveland Clinic Health System接受减重手术、体重指数≥35的成人患者,手术组按1:3匹配未手术的肥胖患者为对照组,数据来源于电子健康记录,随访至2021年3月1日。

主要发现

  • 共纳入20212例患者,中位年龄46岁(IQR 35-57),女性占77.6%(15690例),中位体重指数45(IQR 41-51),总体中位随访6.1年(IQR 3.8-9.0)。
  • COVID-19暴发前,手术组较对照组10年减重多18.6个百分点(95%CI 18.4-18.7,P<.001),10年全因非COVID-19累积死亡率更低(4.7%[95%CI 3.7%-5.7%] vs 9.4%[95%CI 8.7%-10.1%],P<.001)。
  • 2020年3月1日可评估COVID-19结局的患者共11809例,手术组与对照组SARS-CoV-2阳性率相当(9.1%[95%CI 7.9%-10.3%] vs 8.7%[95%CI 8.0%-9.3%],P=.71)。
  • 减重手术与较低的住院风险(校正HR 0.51,95%CI 0.35-0.76,P<.001)、需补氧风险(校正HR 0.37,95%CI 0.23-0.61,P<.001)和重症COVID-19风险(校正HR 0.40,95%CI 0.18-0.86,P=.02)相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Obesity is an established risk factor for severe COVID-19 infection. However, it is not known whether losing weight is associated with reduced adverse outcomes of COVID-19 infection. OBJECTIVE: To investigate the association between a successful weight loss intervention and improved risk and severity of COVID-19 infection in patients with obesity. DESIGN, SETTING, AND PARTICIPANTS: This cohort study involved adult patients with a body mass index of 35 or higher (calculated as weight in kilograms divided by height in meters squared) who underwent weight loss surgery between January 1, 2004, and December 31, 2017, at the Cleveland Clinic Health System (CCHS). Patients in the surgical group were matched 1:3 to patients who did not have surgical intervention for their obesity (control group). The source of data was the CCHS electronic health record. Follow-up was conducted through March 1, 2021. EXPOSURES: Weight loss surgery including Roux-en-Y gastric bypass and sleeve gastrectomy. MAIN OUTCOMES AND MEASURES: Distinct outcomes were examined before and after COVID-19 outbreak on March 1, 2020. Weight loss and all-cause mortality were assessed between the enrollment date and March 1, 2020. Four COVID-19-related outcomes were analyzed in patients with COVID-19 diagnosis between March 1, 2020, and March 1, 2021: positive SARS-CoV-2 test result, hospitalization, need for supplemental oxygen, and severe COVID-19 infection (a composite of intensive care unit admission, need for mechanical ventilation, or death). RESULTS: A total of 20 212 patients (median [IQR] age, 46 [35-57] years; 77.6% female individuals [15 690]) with a median (IQR) body mass index of 45 (41-51) were enrolled. The overall median (IQR) follow-up duration was 6.1 (3.8-9.0) years. Before the COVID-19 outbreak, patients in the surgical group compared with control patients lost more weight (mean difference at 10 years from baseline: 18.6 [95% CI, 18.4-18.7] percentage points; P < .001) and had a 53% lower 10-year cumulative incidence of all-cause non-COVID-19 mortality (4.7% [95% CI, 3.7%-5.7%] vs 9.4% [95% CI, 8.7%-10.1%]; P < .001). Of the 20 212 enrolled patients, 11 809 were available on March 1, 2020, for an assessment of COVID-19-related outcomes. The rates of positive SARS-CoV-2 test results were comparable in the surgical and control groups (9.1% [95% CI, 7.9%-10.3%] vs 8.7% [95% CI, 8.0%-9.3%]; P = .71). However, undergoing weight loss surgery was associated with a lower risk of hospitalization (adjusted hazard ratio [HR], 0.51; 95% CI, 0.35-0.76; P < .001), need for supplemental oxygen (adjusted HR, 0.37; 95% CI, 0.23-0.61; P < .001), and severe COVID-19 infection (adjusted HR, 0.40; 95% CI, 0.18-0.86; P = .02). CONCLUSIONS AND RELEVANCE: This cohort study found that, among patients with obesity, substantial weight loss achieved with surgery was associated with improved outcomes of COVID-19 infection. The findings suggest that obesity can be a modifiable risk factor for the severity of COVID-19 infection.

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. Aminian A, Tu C, Milinovich A, et al. Association of Weight Loss Achieved Through Metabolic Surgery With Risk and Severity of COVID-19 Infection. JAMA Surg. 2022. PMID: 34964827. doi:10.1001/jamasurg.2021.6496

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。